ArticleTrials2021

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study-the BeNeBio study.

Lara S van der Schoot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.